Oxycodone (OxyContin, Percocet, Roxicodone): Dependence, Withdrawal, and Recovery Support

Oxycodone is the opioid inside OxyContin, Percocet, and Roxicodone, and for many families it is the drug that turned a surgery into something much bigger. From 1999 to 2023, nearly 308,000 people in the United States died from overdoses involving prescription opioids, and the CDC lists oxycodone among the drugs most often involved (CDC, 2025). It is hard to stop because the immediate-release form wears off within hours, so a dependent body asks for more the same day, and because the pills sold outside a pharmacy are now mostly fentanyl pressed to look like oxycodone. This page covers dependence, withdrawal, why the real danger comes after withdrawal rather than during it, treatment, and how ongoing support at home fits once a prescriber is involved.

What oxycodone is and how it works

The DEA describes oxycodone as "a semi-synthetic narcotic analgesic" with a long history of misuse (DEA fact sheet). The immediate-release tablet, Roxicodone, is approved "for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate" (Roxicodone prescribing information, section 1). OxyContin, the extended-release tablet, is held to a higher bar: "severe and persistent pain that requires an opioid analgesic and that cannot be adequately treated with alternative options, including immediate-release opioids" (OxyContin prescribing information, section 1).

Percocet pairs oxycodone with acetaminophen in 2.5, 5, 7.5, and 10 mg strengths, each with 325 mg of acetaminophen (Percocet prescribing information). Roxicodone comes as 15 and 30 mg tablets. On the street the DEA lists "Hillbilly Heroin, Kicker, OC, Ox, Roxy, Perc, Oxy" (DEA); members also say "percs," "roxies," "30s," and "blues" for the 30 mg tablets.

Oxycodone binds to the mu-opioid receptor, which produces the pain relief, the warmth, and the slowed breathing. The liver clears it mostly through the enzyme CYP3A4: "A high portion of oxycodone is N-dealkylated to noroxycodone during first-pass metabolism, and is catalyzed by CYP3A4" (Roxicodone, section 12.3), which matters later because many common medications block that enzyme. It is also short-acting. The "apparent elimination half-life of oxycodone following the administration of ROXICODONE was 3.5 to 4 hours" (section 12.3). OxyContin "is designed to provide delivery of oxycodone over 12 hours," with an apparent half-life of "4.5 hours compared to 3.2 hours for immediate-release oxycodone" (OxyContin prescribing information, 2010). Crushing the original tablet delivered all 12 hours at once, so in April 2010 the FDA approved a reformulated version (FDA timeline). The current label says it "is formulated with inactive ingredients intended to make the tablet more difficult to manipulate for misuse and abuse," then adds, "However, abuse of OXYCONTIN by these routes, as well as by the oral route, is still possible" (OxyContin, section 9.2).

Oxycodone is a Schedule II controlled substance, which the DEA defines as "drugs with a high potential for abuse, with use potentially leading to severe psychological or physical dependence" (DEA drug scheduling).

The counterfeit pill is what has changed most in the past decade. The DEA reports that "The majority of counterfeit pills resemble oxycodone 30mg pills (M30s)," sold as "Mexican Blues, Blues, M-Boxes" (DEA, 2021). These pills are fentanyl, not oxycodone. DEA laboratory testing found that "7 out of every 10 pills with fentanyl contain a potentially lethal dose" (DEA, September 2023), and the agency seized "more than 47 million fentanyl-laced counterfeit pills" in 2025 alone (DEA, One Pill Can Kill). If someone you love is buying "30s," you are having a fentanyl conversation.

Dependence, misuse, and addiction are not the same thing

People use these words interchangeably, and the confusion produces shame that helps no one. The label draws the lines. "Physical dependence is a state that develops as a result of a physiological adaptation in response to repeated drug use, manifested by withdrawal signs and symptoms after abrupt discontinuation or a significant dose reduction of a drug" (Roxicodone, section 9.3). Dependence happens to the retired teacher who took Percocet exactly as directed after a knee replacement. It is pharmacology, not character.

Misuse is taking it in a way it was not prescribed: more, sooner, crushed, or from someone else's bottle. Addiction, in clinical language an opioid use disorder, is the pattern of continuing despite harm: early refills, a second prescriber, pills from a coworker and then from a dealer, and a day that quietly reorganizes itself around the next dose. The OxyContin label is direct: "Addiction can occur at recommended doses and if the drug is misused or abused" (OxyContin, section 5.1). Someone can be dependent without being addicted, and addicted at a dose that looks modest on paper. The question we ask families is what the pill has started to cost.

Signs oxycodone has become a problem

Here is what families describe to us most often. The prescription runs out a week early, month after month. There is a low, sweaty stretch before the next dose and a visible lift after it. A tablet has been crushed or chewed, which the boxed warning says "can cause rapid release and absorption of a potentially fatal dose of oxycodone" (OxyContin boxed warning). Someone is nodding off mid-sentence; the DEA lists "extreme drowsiness, muscle weakness, confusion, cold and clammy skin, pinpoint pupils, shallow breathing" among the signs of too much (DEA). Money is missing. The pills now come in a baggie rather than a bottle, which means they are almost certainly not oxycodone at all. Any one of these is worth a conversation. Several together are worth a call.

Why stopping oxycodone is rarely the dangerous part

Opioid withdrawal feels awful and almost never kills anyone. The WHO's withdrawal management guideline says it "can feel like a very bad flu," but "opioid withdrawal is not usually life-threatening" (WHO, 2009). Alcohol and benzodiazepine withdrawal can be fatal. Oxycodone withdrawal, on its own, is not in that category.

The danger sits in two other places. The first is abrupt stopping in a person with pain. The label warns that "Rapid reduction or abrupt discontinuation of opioid analgesics in patients who are physically dependent on opioids has resulted in serious withdrawal symptoms, uncontrolled pain, and suicide" (OxyContin, section 2.9).

The second is the one that fills obituaries. Tolerance drops fast, and last month's normal dose can stop a person's breathing. The WHO guideline says that "All opioid dependent patients who have withdrawn from opioids should be advised that they are at increased risk of overdose due to reduced opioid tolerance" (WHO). SAMHSA's overdose toolkit lists "using drugs after a recent period of abstinence, which may decrease previous tolerance levels" among the leading risk factors, along with returning to use after leaving jail or a treatment setting without medication for opioid use disorder (SAMHSA, 2023). Add the fact that a "30" bought today is probably fentanyl, and you have the reason we treat the weeks after withdrawal as the highest-risk stretch rather than the finish line.

Oxycodone withdrawal timeline

The label's list of withdrawal signs runs from "restlessness, lacrimation, rhinorrhea, yawning, perspiration, chills, myalgia, mydriasis" through anxiety, backache, cramps, insomnia, nausea, vomiting, and diarrhea (Roxicodone, section 9.3). Timing depends on the form, the dose, and the duration. The WHO gives the shape for short-acting opioids as "Onset of opioid withdrawal symptoms 8-24 hours after last use; duration 4-10 days" (WHO, 2009). Everyone is different; treat this as the general shape.

First 8 to 24 hours

With a half-life under four hours, immediate-release oxycodone leaves quickly. Early signs are yawning, a runny nose, watery eyes, sweating, goosebumps, anxiety, and the sense that something is wrong. People on OxyContin may start a little later.

Days 2 to 4

This is the peak: body aches, cramps, diarrhea, vomiting, chills and sweats, restless legs, insomnia. Dehydration is the one physical complication worth watching; the WHO guideline recommends 2 to 3 liters of fluid a day (WHO). This is also where "just one to sleep" happens, which is why a plan for these exact nights matters more than resolve.

Days 5 to 10

The physical symptoms fade for most people. Sleep is still broken, and cravings attach to the situations oxycodone used to handle: a pain flare, a bad shift, the quiet after the kids are in bed.

Weeks 2 and beyond

Low mood, anxiety, poor sleep, and a flatness that makes everything feel like work can hang on for weeks. This is where people quietly return to use, and where lost tolerance makes that return most dangerous.

How treatment works

For someone physically dependent on a prescribed dose, the label's guidance is a slow taper: "initiate the taper by a small enough increment (e.g., no greater than 10% to 25% of the total daily dose) to avoid withdrawal symptoms, and proceed with dose-lowering at an interval of every 2 to 4 weeks." If symptoms appear, "it may be necessary to pause the taper for a period of time or raise the dose of the opioid analgesic to the previous dose, and then proceed with a slower taper" (OxyContin, section 2.9). For someone on 60 mg a day, the first step down is 6 to 15 mg, and the whole thing runs months.

For someone whose use has become an opioid use disorder, the standard of care is medication. SAMHSA's TIP 63 covers the three FDA-approved options, methadone, buprenorphine, and naltrexone, and states that they reduce illicit opioid use, keep people in treatment, and lower the risk of overdose death compared with placebo or no medication (SAMHSA TIP 63, Part 1). It is blunt about detox alone: "Most patients with OUD who undergo medically supervised withdrawal will start using opioids again and won't continue in recommended care," and "Arbitrary time limits on the duration of treatment with OUD medication are inadvisable." The ASAM guideline agrees: "There is no recommended time limit for pharmacological treatment" (ASAM, 2020).

Naloxone belongs in every house where oxycodone is. The label tells prescribers to "Inform patients and caregivers about opioid overdose reversal agents (e.g., naloxone, nalmefene)" (Roxicodone, section 2.2). Narcan 4 mg nasal spray has been sold without a prescription since the FDA approved over-the-counter use on March 29, 2023 (FDA). Buy two.

Oxycodone with alcohol, benzodiazepines, or other drugs

Oxycodone kills in combination, at a dose the body is no longer used to, or when the pill turns out to be fentanyl. The boxed warning states that "Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death" (Roxicodone boxed warning). The Xanax at bedtime and the two beers after work add up to the overdose pattern.

Two interactions are specific to oxycodone. Because CYP3A4 clears it, anything that blocks that enzyme raises the blood level. The label warns that a CYP3A4 inhibitor "such as macrolide antibiotics (e.g., erythromycin), azole-antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), may increase plasma concentrations of oxycodone and prolong opioid adverse reactions, which may cause potentially fatal respiratory depression" (section 5.6). The other is acetaminophen. Ten Percocet a day is also 3,250 mg of acetaminophen, and the Percocet boxed warning notes that most cases of liver injury involve "doses that exceed 4000 milligrams per day, and often involve more than one acetaminophen-containing product" (Percocet prescribing information).

The national picture has improved. Drug overdose deaths fell from 105,007 in 2023 to 79,384 in 2024, a 26.2 percent drop, and the death rate involving natural and semisynthetic opioids, the CDC category that includes oxycodone, fell 20.7 percent, from 2.9 to 2.3 per 100,000 (CDC NCHS Data Brief 549, 2026).

Drug testing for oxycodone

The standard "opiates" line on most panels will miss it. The American College of Medical Toxicology explains that "Most clinical immunoassays for opiates have morphine and codeine as their target analytes," and that "Separate assays are required to reliably detect" fentanyl, hydrocodone, oxycodone, and the other semisynthetic and synthetic opioids (ACMT, 2021). A negative five-panel test says nothing about oxycodone unless a specific assay was on it. The same goes for fentanyl.

Saliva data come mostly from single doses in healthy volunteers. In one controlled study, 12 adults took a 20 mg controlled-release dose, and "At a 1 ng/mL cutoff for OF, the mean detection time was 34 h" for oxycodone and its metabolite noroxycodone (Cone et al., J Anal Toxicol, 2015). Daily use at higher doses extends that, and the lab's cutoff moves it, so we would rather not quote one number for everyone. A prescribed, tapering dose will test positive; what matters is whether the result matches the plan.

Our members use saliva-based screening that is assigned at random through the week. You do not choose whether you test; you choose who sees the results. For most members that means the prescriber and, if they want, a spouse or parent. We explain the details in our guide to how sobriety monitoring works.

How recovery from oxycodone works with Accountable

We are not a detox and we do not prescribe. The taper or the buprenorphine belongs to your doctor. What we provide is the support around it, at home, for as long as you need it.

1. Get the full picture

In the first sessions your coach maps what is actually going on: which product, how much, for how long, whether the pills come from a pharmacy or a phone, and whether benzodiazepines, alcohol, or untreated pain are in the picture. If there is no prescriber managing a taper or medication for opioid use disorder yet, we help you find one, and with your permission we coordinate so everyone works from the same plan.

2. Build a plan that fits your life

A plan that only works if you take a month off is a plan you will abandon. Your coach helps you plan around the real calendar: what you will do when a pain flare hits, which nights the cravings run hottest, who you will text before you text the old contact. Daily peer group meetings and a weekly family Zoom group give the people around you their own place to get support.

3. Weekly check-ins through the long stretch

The flat, restless weeks after oxycodone are where people quietly give up, and where a return to the old dose is most likely to be fatal. Your coach shows up every week, and the saliva screening turns "I think he's doing okay" into a shared record that you control. When a slip happens, we treat it as information: the plan changes, the support goes up, and we check that the naloxone is still in the drawer. Every coach at Accountable has their own recovery behind them, and many have been through opioids.

Accountable is covered by a growing list of commercial health plans, with more added each month, and private-pay plans start at $375 per month. You can check your coverage in a few minutes or call the care team at (646) 450-7641. Families are welcome to make the first call; see our page for families.

Common questions

How long does oxycodone stay in your system?

The half-life of immediate-release oxycodone is 3.5 to 4 hours (Roxicodone, section 12.3), so most of a single dose is gone within a day. In saliva, one controlled study found a mean detection time of 34 hours after a single 20 mg controlled-release dose (Cone et al., 2015). Regular use extends detection, and urine windows are longer.

How long does oxycodone withdrawal last?

For short-acting opioids the WHO puts onset at 8 to 24 hours after the last dose and duration at 4 to 10 days (WHO, 2009). Sleep, mood, and cravings can take weeks longer, and a taper of 10 to 25 percent every two to four weeks keeps most of this mild (OxyContin, section 2.9).

Is oxycodone withdrawal dangerous?

Rarely on its own; the WHO calls it "not usually life-threatening" (WHO). The two real risks are abrupt discontinuation in someone with serious pain, which the label links to "uncontrolled pain, and suicide" (OxyContin, section 2.9), and overdose after tolerance has dropped. Taper with a prescriber and keep naloxone close.

Does oxycodone show up on a drug test?

Not reliably on a standard opiate screen. Oxycodone needs its own assay (ACMT). If a test is meant to check for oxycodone or fentanyl, confirm that both are on the panel.

What should I do if someone on oxycodone will not wake up?

Call 911, give naloxone, and give rescue breaths if they are not breathing; otherwise put them on their side. SAMHSA's toolkit says "Naloxone and nalmefene do not cause harm if given to a person who is not experiencing opioid overdose" (SAMHSA, 2023). Naloxone "rapidly reverses the effects of opioid overdose" (FDA), but it can wear off before an extended-release tablet does, so they still need emergency care.

Sources

• U.S. Food and Drug Administration. OxyContin (oxycodone hydrochloride) extended-release tablets, prescribing information, revised December 2025.

• U.S. Food and Drug Administration. OxyContin (oxycodone hydrochloride) extended-release tablets, prescribing information, revised December 2023 (section 9.2, abuse-deterrent formulation).

• U.S. Food and Drug Administration. OxyContin (oxycodone hydrochloride controlled-release) tablets, prescribing information, 2010 (clinical pharmacology, half-life).

• U.S. Food and Drug Administration. Roxicodone (oxycodone hydrochloride) tablets, prescribing information, revised December 2025.

• U.S. Food and Drug Administration. Percocet (oxycodone and acetaminophen tablets, USP), prescribing information, revised July 2018.

• U.S. Food and Drug Administration. Timeline of Selected FDA Activities and Significant Events Addressing Substance Use and Overdose Prevention.

• U.S. Food and Drug Administration. FDA Approves First Over-the-Counter Naloxone Nasal Spray. Press announcement, March 29, 2023.

• Drug Enforcement Administration. Oxycodone drug fact sheet.

• Drug Enforcement Administration. Drug Scheduling.

• Drug Enforcement Administration. Counterfeit Pills, fact sheet, May 2021.

• Drug Enforcement Administration. Fake Prescription Pills: Widely Available, Increasingly Lethal, One Pill Can Kill fact sheet, September 2023.

• Drug Enforcement Administration. One Pill Can Kill.

• Centers for Disease Control and Prevention, National Center for Health Statistics. Garnett MF, Miniño AM. Drug Overdose Deaths in the United States, 2023-2024. NCHS Data Brief No. 549, January 2026.

• Centers for Disease Control and Prevention. Prescription Opioids. Overdose Prevention, last reviewed June 10, 2025.

• World Health Organization. Clinical Guidelines for Withdrawal Management and Treatment of Drug Dependence in Closed Settings, chapter 4: Withdrawal Management. 2009, NCBI Bookshelf.

• Substance Abuse and Mental Health Services Administration. TIP 63: Medications for Opioid Use Disorder, Part 1: Introduction to Medications for Opioid Use Disorder Treatment. 2021 update, NCBI Bookshelf.

• Substance Abuse and Mental Health Services Administration. Overdose Prevention and Response Toolkit. PEP23-03-00-001, 2023.

• American Society of Addiction Medicine. Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder. 2020.

• Stolbach AI, Connors NJ, Nelson LS, Kulig K. ACMT Practice Statement: Interpretation of Urine Opiate and Opioid Tests. American College of Medical Toxicology, September 13, 2021.

• Cone EJ, DePriest AZ, Heltsley R, Black DL, Mitchell JM, LoDico C, Flegel R. Prescription Opioids. III. Disposition of Oxycodone in Oral Fluid and Blood Following Controlled Single-Dose Administration. Journal of Analytical Toxicology. 2015;39(3):192-202.